Ekterly (sebetralstat) for hereditary angioedema: the first FDA-approved oral on-demand therapy
- DOI
- 10.1097/ms9.0000000000005115
- Published
- 2026-05-19
- Container
- Annals of Medicine & Surgery
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/ms9.0000000000005115,
title = {Ekterly (sebetralstat) for hereditary angioedema: the first FDA-approved oral on-demand therapy},
author = {Dua Asim and Zoha Idrees and Muhammad Anas Faheem and Jaber Hamad Jaber Amin},
year = {2026},
journal = {Annals of Medicine \& Surgery},
doi = {10.1097/ms9.0000000000005115},
url = {https://doi.org/10.1097/ms9.0000000000005115}
}RIS
TY - JOUR TI - Ekterly (sebetralstat) for hereditary angioedema: the first FDA-approved oral on-demand therapy AU - Dua Asim AU - Zoha Idrees AU - Muhammad Anas Faheem AU - Jaber Hamad Jaber Amin PY - 2026 JO - Annals of Medicine & Surgery DO - 10.1097/ms9.0000000000005115 UR - https://doi.org/10.1097/ms9.0000000000005115 ER -
APA
Asim, D., Idrees, Z., Faheem, M. A., & Amin, J. H. J. (2026). Ekterly (sebetralstat) for hereditary angioedema: the first FDA-approved oral on-demand therapy. Annals of Medicine & Surgery. https://doi.org/10.1097/ms9.0000000000005115
Source records
- crossref · retrieved 2026-09-26T11:47:54.445Z